Published in Mol Cell Biol on February 01, 2005
POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J (2005) 2.69
Conserved telomere maintenance component 1 interacts with STN1 and maintains chromosome ends in higher eukaryotes. Mol Cell (2009) 2.62
Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis. EMBO J (2007) 2.61
Telomere length homeostasis. Chromosoma (2006) 2.12
A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assembly. Proc Natl Acad Sci U S A (2006) 2.04
DNA damage response at functional and dysfunctional telomeres. Genes Dev (2008) 1.75
POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination. EMBO J (2006) 1.66
Telomere protection by TPP1 is mediated by POT1a and POT1b. Mol Cell Biol (2009) 1.66
Telomere protection by TPP1/POT1 requires tethering to TIN2. Mol Cell (2011) 1.62
The Arabidopsis Pot1 and Pot2 proteins function in telomere length homeostasis and chromosome end protection. Mol Cell Biol (2005) 1.52
STN1 protects chromosome ends in Arabidopsis thaliana. Proc Natl Acad Sci U S A (2008) 1.46
Telomere recombination requires the MUS81 endonuclease. Nat Cell Biol (2009) 1.45
Telomere biology in healthy aging and disease. Pflugers Arch (2009) 1.41
Arabidopsis POT1 associates with the telomerase RNP and is required for telomere maintenance. EMBO J (2007) 1.38
The mechanism of telomere protection: a comparison between Drosophila and humans. Chromosoma (2005) 1.35
Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin/IGF-1 signaling and telomere maintenance pathways. Age (Dordr) (2011) 1.26
Vertebrate POT1 restricts G-overhang length and prevents activation of a telomeric DNA damage checkpoint but is dispensable for overhang protection. Mol Cell Biol (2006) 1.23
Pot1 and telomere maintenance. FEBS Lett (2010) 1.18
Distinct functions of POT1 at telomeres. Mol Cell Biol (2008) 1.18
Factors that influence telomeric oxidative base damage and repair by DNA glycosylase OGG1. DNA Repair (Amst) (2010) 1.17
Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence. Nat Cell Biol (2010) 1.14
Telomere dysfunction and cell survival: roles for distinct TIN2-containing complexes. J Cell Biol (2008) 1.14
Genome-wide YFP fluorescence complementation screen identifies new regulators for telomere signaling in human cells. Mol Cell Proteomics (2010) 1.12
Distinct requirements for Pot1 in limiting telomere length and maintaining chromosome stability. Mol Cell Biol (2005) 1.07
Separation of telomerase functions by reverse genetics. Proc Natl Acad Sci U S A (2011) 1.07
Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells. Breast Cancer Res (2007) 1.06
POT1 association with TRF2 regulates telomere length. Mol Cell Biol (2009) 1.01
Alterations of DNA and chromatin structures at telomeres and genetic instability in mouse cells defective in DNA polymerase alpha. Mol Cell Biol (2005) 0.97
Inhibition of yeast telomerase action by the telomeric ssDNA-binding protein, Cdc13p. Nucleic Acids Res (2008) 0.94
p53 governs telomere regulation feedback too, via TRF2. Aging (Albany NY) (2011) 0.93
The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. PLoS One (2010) 0.92
Schizosaccharomyces pombe protection of telomeres 1 utilizes alternate binding modes to accommodate different telomeric sequences. Biochemistry (2011) 0.92
Endogenous hSNM1B/Apollo interacts with TRF2 and stimulates ATM in response to ionizing radiation. DNA Repair (Amst) (2008) 0.88
Modulation of telomere terminal structure by telomerase components in Candida albicans. Nucleic Acids Res (2006) 0.88
The breast cancer susceptibility gene BRCA2 is required for the maintenance of telomere homeostasis. J Biol Chem (2011) 0.88
Phosphorylation of ribosomal protein S6 confers PARP inhibitor resistance in BRCA1-deficient cancers. Oncotarget (2014) 0.85
Characterization of the DNA binding specificity of Shelterin complexes. Nucleic Acids Res (2011) 0.84
Telomerase enzymatic component hTERT shortens long telomeres in human cells. Cell Cycle (2014) 0.84
Akt1 inhibits homologous recombination in Brca1-deficient cells by blocking the Chk1-Rad51 pathway. Oncogene (2012) 0.82
Trastuzumab increases the sensitivity of HER2-amplified human gastric cancer cells to oxaliplatin and cisplatin by affecting the expression of telomere-associated proteins. Oncol Lett (2014) 0.82
Telomere replication: poised but puzzling. J Cell Mol Med (2011) 0.82
CGGBP1 phosphorylation constitutes a telomere-protection signal. Cell Cycle (2013) 0.81
POT of gold: modeling dyskeratosis congenita in the mouse. Genes Dev (2008) 0.81
Altered expression of TPP1 in fibroblast-like synovial cells might be involved in the pathogenesis of rheumatoid arthritis. Rheumatol Int (2011) 0.81
Fission yeast Pot1 and RecQ helicase are required for efficient chromosome segregation. Mol Cell Biol (2010) 0.79
Binding linkage in a telomere DNA-protein complex at the ends of Oxytricha nova chromosomes. J Mol Biol (2005) 0.79
DNA damage to a single chromosome end delays anaphase onset. J Biol Chem (2014) 0.77
The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines. Breast Cancer Res Treat (2014) 0.76
Suppression of hPOT1 in diploid human cells results in an hTERT-dependent alteration of telomere length dynamics. Mol Cancer Res (2008) 0.76
Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences. Cell Death Dis (2017) 0.75
SmedOB1 is Required for Planarian Homeostasis and Regeneration. Sci Rep (2016) 0.75
16th international charles heidelberger symposium on cancer research coimbra, portugal. 26-28 september 2010. Abstracts. BMC Proc (2010) 0.75
Means to the ends: The role of telomeres and telomere processing machinery in metastasis. Biochim Biophys Acta (2016) 0.75
Critical role of the POT1 OB domain in maintaining genomic stability. Oncogene (2016) 0.75
A small molecule inhibitor of Pot1 binding to telomeric DNA. Biochemistry (2012) 0.75
The OB-fold domain 1 of human POT1 recognizes both telomeric and non-telomeric DNA motifs. Biochimie (2015) 0.75
Extension of life-span by introduction of telomerase into normal human cells. Science (1998) 20.48
Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science (2003) 18.29
Mammalian telomeres end in a large duplex loop. Cell (1999) 12.12
Switching and signaling at the telomere. Cell (2001) 11.25
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J (1992) 10.97
TRF2 protects human telomeres from end-to-end fusions. Cell (1998) 10.13
DNA damage foci at dysfunctional telomeres. Curr Biol (2003) 9.08
Control of telomere length by the human telomeric protein TRF1. Nature (1997) 7.62
Pot1, the putative telomere end-binding protein in fission yeast and humans. Science (2001) 6.95
Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med (1997) 6.55
p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science (1999) 5.89
Telomere states and cell fates. Nature (2000) 5.71
POT1 as a terminal transducer of TRF1 telomere length control. Nature (2003) 5.43
Telomerase activity in human germline and embryonic tissues and cells. Dev Genet (1996) 5.00
Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell (1997) 4.86
A human telomeric protein. Science (1995) 4.77
Control of human telomere length by TRF1 and TRF2. Mol Cell Biol (2000) 4.54
The age of cancer. Nature (2000) 4.32
Senescence induced by altered telomere state, not telomere loss. Science (2002) 4.17
Cdc13 delivers separate complexes to the telomere for end protection and replication. Cell (2001) 3.95
The Bloom's syndrome gene product interacts with topoisomerase III. J Biol Chem (2000) 3.52
Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev (1997) 3.42
PTOP interacts with POT1 and regulates its localization to telomeres. Nat Cell Biol (2004) 3.33
Telomerase maintains telomere structure in normal human cells. Cell (2003) 3.29
T-loop assembly in vitro involves binding of TRF2 near the 3' telomeric overhang. EMBO J (2001) 3.28
POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev (2004) 3.25
Crystal structure of the Oxytricha nova telomere end binding protein complexed with single strand DNA. Cell (1998) 3.03
Different telomere damage signaling pathways in human and mouse cells. EMBO J (2002) 2.87
The terminal DNA structure of mammalian chromosomes. EMBO J (1997) 2.63
T-loops and the origin of telomeres. Nat Rev Mol Cell Biol (2004) 2.54
Historical claims and current interpretations of replicative aging. Nat Biotechnol (2002) 2.38
TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres. J Biol Chem (2004) 2.36
Cell cycle-regulated generation of single-stranded G-rich DNA in the absence of telomerase. Proc Natl Acad Sci U S A (1996) 2.22
Stringent sequence requirements for the formation of human telomeres. Proc Natl Acad Sci U S A (1994) 2.16
Functional reintroduction of human telomeres into mammalian cells. Proc Natl Acad Sci U S A (1991) 2.10
DNA self-recognition in the structure of Pot1 bound to telomeric single-stranded DNA. Nature (2003) 2.08
Chromatin structure of the molecular ends of Oxytricha macronuclear DNA: phased nucleosomes and a telomeric complex. Cell (1984) 1.97
DNA binding features of human POT1: a nonamer 5'-TAGGGTTAG-3' minimal binding site, sequence specificity, and internal binding to multimeric sites. J Biol Chem (2004) 1.83
Erosion of the telomeric single-strand overhang at replicative senescence. Nat Genet (2003) 1.78
Telomere dysfunction and the initiation of genome instability. Nat Rev Cancer (2003) 1.69
Human Pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing. Mol Cell Biol (2002) 1.69
Telomeres, aging and cancer: in search of a happy ending. Oncogene (2002) 1.69
Human POT1 facilitates telomere elongation by telomerase. Curr Biol (2003) 1.64
Telomerase: a target for cancer therapeutics. Cancer Cell (2002) 1.64
Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett (2003) 1.57
Cdc13 prevents telomere uncapping and Rad50-dependent homologous recombination. EMBO J (2001) 1.41
p53-mediated apoptosis is attenuated in Werner syndrome cells. Genes Dev (1999) 1.39
Cooperative binding of single-stranded telomeric DNA by the Pot1 protein of Schizosaccharomyces pombe. Biochemistry (2002) 1.38
Evidence that exposure of the telomere 3' overhang sequence induces senescence. Proc Natl Acad Sci U S A (2003) 1.37
Rescue of an hTERT mutant defective in telomere elongation by fusion with hPot1. Mol Cell Biol (2004) 1.27
Dynamics of protein binding to telomeres in living cells: implications for telomere structure and function. Mol Cell Biol (2004) 1.25
Telomeres and telomerase in aging, regeneration and cancer. Mol Cells (2003) 1.22
Mammalian telomeres and telomerase: why they matter for cancer and aging. Eur J Cell Biol (2003) 1.16
The length of telomeric G-rich strand 3'-overhang measured by oligonucleotide ligation assay. Nucleic Acids Res (2001) 1.14
Telomere repeat binding factors: keeping the ends in check. Cancer Lett (2003) 1.13
Molecular manifestations and molecular determinants of telomere capping. Cold Spring Harb Symp Quant Biol (2000) 1.12
Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res (2004) 1.10
Cell cycle localization, dimerization, and binding domain architecture of the telomere protein cPot1. Mol Cell Biol (2004) 1.05
Cell biology. Telomere capping--one strand fits all. Science (2001) 1.01
Why do we have linear chromosomes? A matter of Adam and Eve. Mutat Res (1999) 0.92
A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell (2006) 23.59
The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat (2002) 12.39
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA (2008) 12.26
Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer (2010) 7.39
Radical causes of cancer. Nat Rev Cancer (2003) 5.45
KIF5B-RET fusions in lung adenocarcinoma. Nat Med (2012) 4.38
Inflammation and cancer: an ancient link with novel potentials. Int J Cancer (2007) 4.19
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A (2009) 3.64
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol (2010) 3.49
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis (2009) 3.40
The landscape of recombination in African Americans. Nature (2011) 3.06
MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res (2009) 3.03
p53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol (2005) 2.78
The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med (2008) 2.72
Reprogramming of miRNA networks in cancer and leukemia. Genome Res (2010) 2.65
Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. J Natl Cancer Inst (2011) 2.61
Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One (2011) 2.57
p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat Cell Biol (2009) 2.46
Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res (2008) 2.45
p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res (2003) 2.40
Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology (2002) 2.38
TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci Publ (2004) 2.23
TP53 and liver carcinogenesis. Hum Mutat (2003) 2.23
p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res (2004) 2.08
p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Mol Syst Biol (2008) 2.04
Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci U S A (2002) 2.04
BLM heterozygosity and the risk of colorectal cancer. Science (2002) 2.03
Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer (2011) 2.02
Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res (2003) 1.97
Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One (2009) 1.94
MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res (2010) 1.89
Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc Natl Acad Sci U S A (2004) 1.87
Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation. Cancer Res (2005) 1.86
Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell (2013) 1.86
Advances in chemical carcinogenesis: a historical review and prospective. Cancer Res (2008) 1.83
Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest. J Cell Biol (2004) 1.82
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. J Clin Invest (2003) 1.82
BLM helicase-dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination. EMBO J (2003) 1.71
Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer. Clin Cancer Res (2005) 1.70
Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-β signaling. PLoS Genet (2013) 1.69
Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res (2009) 1.67
Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proc Natl Acad Sci U S A (2010) 1.66
Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. Cancer Res (2003) 1.64
Clinical outcomes and correlates of TP53 mutations and cancer. Cold Spring Harb Perspect Biol (2010) 1.64
The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res (2012) 1.61
Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis (2005) 1.61
Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. J Natl Cancer Inst (2007) 1.58
Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. Cancer Res (2002) 1.53
p53: 25 years after its discovery. Trends Pharmacol Sci (2004) 1.49
Telomere recombination requires the MUS81 endonuclease. Nat Cell Biol (2009) 1.45
Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo. Cancer Res (2004) 1.45
Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type. Mol Cell Proteomics (2008) 1.44
Lung cancer in never smokers: molecular profiles and therapeutic implications. Clin Cancer Res (2009) 1.44
The role of microRNAs in colorectal cancer. Cancer J (2012) 1.44
The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer Res (2005) 1.42
A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis. Oncogene (2003) 1.40
WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res (2009) 1.39
Molecular pathogenesis of human hepatocellular carcinoma. Toxicology (2002) 1.35
p53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria. Oncogene (2004) 1.33
p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res (2003) 1.32
ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation. Mol Cell Biol (2005) 1.31
Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. Carcinogenesis (2003) 1.31
The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin Cancer Res (2011) 1.29
Nitric oxide in cancer and chemoprevention. Free Radic Biol Med (2003) 1.29
Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. Gastroenterology (2010) 1.28
Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility. J Biol Chem (2006) 1.28
Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum (2013) 1.28
Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. Cancer Res (2011) 1.27
Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis (2004) 1.25
ING1 represses transcription by direct DNA binding and through effects on p53. Cancer Res (2003) 1.25
Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis. Int J Cancer (2006) 1.23
Superoxide fluxes limit nitric oxide-induced signaling. J Biol Chem (2006) 1.22
Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer (2010) 1.22
The processing of Holliday junctions by BLM and WRN helicases is regulated by p53. J Biol Chem (2002) 1.22
p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes. J Clin Invest (2013) 1.21
Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray. Hum Pathol (2004) 1.20
Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res (2008) 1.19
Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1. Cancer Res (2007) 1.19
Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol (2011) 1.19
Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res (2012) 1.18
Nitric oxide, a mediator of inflammation, suppresses tumorigenesis. Cancer Res (2004) 1.15
Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence. Nat Cell Biol (2010) 1.14
Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation. Proc Natl Acad Sci U S A (2012) 1.13
The role of p53 in base excision repair following genotoxic stress. Carcinogenesis (2003) 1.13
Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy. J Exp Med (2010) 1.12
Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ Mol Mutagen (2004) 1.12
The p53 network in lung carcinogenesis. Oncogene (2002) 1.11
MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PLoS One (2012) 1.11
Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev (2009) 1.10
MDM2 SNP309 and SNP354 are not associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 1.10
Tumor suppressor p53 represses transcription of RECQ4 helicase. Oncogene (2005) 1.10
Reviewing the current classification of inhibitor of growth family proteins. Cancer Sci (2009) 1.09
The reemergence of nitric oxide and cancer. Nitric Oxide (2008) 1.09
Cellular stress induced alterations in microRNA let-7a and let-7b expression are dependent on p53. PLoS One (2011) 1.08
The mismatch DNA repair heterodimer, hMSH2/6, regulates BLM helicase. Oncogene (2004) 1.08